Wednesday, August 08, 2012 11:30:14 AM
8:37 AM ET 8/8/12 | Briefing.com
Reports Q2 (Jun) earnings of $0.29 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.26; revenues fell 8.7% year/year to $15.8 mln vs the $15.51 mln consensus. Co issues downside guidance for Q3, sees Q3 revs down significantly QoQ (from $15.8 mln) vs. $17.85 mln Capital IQ Consensus Estimate. Co issues downside guidance for FY12, sees FY12 revs likely down YoY (from $63.5 mln) vs. $69.11 mln Capital IQ Consensus Estimate. "However, we continue to believe in our long-term, strong growth potential and are now expecting the revenue ramp to start in 2013. It is a very disappointing short term guidance that delays our expected revenue ramp, but we believe it is just a delay that does not change our long term view. We continue to believe that all our NP-4 customers will move to production until the end of the year, carriers to increase spending, the growth in edge routing to resume, and our leadership in high speed network processors to advance."
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM